George Magrath
Directeur Général chez OCUPHIRE PHARMA, INC.
Fortune : 660 050 $ au 30/04/2024
Profil
George Magrath is currently the Chief Executive Officer & Director at Ocuphire Pharma, Inc. He was previously the Chief Executive Officer & Director at Lexitas Pharma Services, Inc. from 2021 to 2023.
Prior to that, he worked as an Analyst at Edison Investment Research, Inc. Dr. Magrath holds a doctorate degree from the Medical University of South Carolina, an MBA from The Citadel, The Military College of South Carolina, an undergraduate degree from Clemson University, and a graduate degree from The Johns Hopkins University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
1,73% | 17/05/2024 | 430 000 ( 1,73% ) | 660 050 $ | 30/04/2024 |
Postes actifs de George Magrath
| Sociétés | Poste | Début |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Directeur Général | 01/11/2023 |
Anciens postes connus de George Magrath
| Sociétés | Poste | Fin |
|---|---|---|
Lexitas Pharma Services , Inc.
 Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Directeur Général | 30/09/2023 |
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | - |
Formation de George Magrath
| The Johns Hopkins University | Graduate Degree |
| The Citadel, The Military College of South Carolina | Masters Business Admin |
| Medical University of South Carolina | Doctorate Degree |
| Clemson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
Lexitas Pharma Services , Inc.
Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Health Services |
